Seeking Alpha

ITMN
  InterMune, Inc. - NASDAQ

9/17/2014, 5:43 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
ITMN vs. ETF Alternatives
Company Description
InterMune, Inc., is a biotechnology company. It is engaged in the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States